Advertisements


Immuron Rips Higher On Positive Preclinical Results For Travelan

Shares of Australian nano-cap biotech Immuron (NASDAQ: IMRN) rose sharply Wednesday on roughly 250 times average volume. Immuron develops oral immunotherapies for preventing and treating gut-mediated pathogens. read more.....»»

Category: blogSource: benzingaJun 12th, 2019

Medicines Company Rallies On Positive LDL Cholesterol Study Results

Small-cap biotech The Medicines Company (NASDAQ: MDCO) announced long-term results over the weekend from a midstage study of its lead product candidate Inclisiran, sending its shares higher. read more.....»»

Category: blogSource: benzingaMay 20th, 2019

Analysts Raise Price Targets On GW Pharma"s Positive Earnings, Epidiolex Results

GW Pharmaceuticals PLC-ADR (NASDAQ: GWPH) opened higher by 8 percent Tuesday after posting positive results from its Phase 3 Epidiolex trial and second-quarter earnings beats. Here’s what analysts are sayin.....»»

Category: earningsSource: benzingaMay 7th, 2019

Wall Street Sets a Higher Floor for AMD

AMD released its most recent quarterly results after the markets closed on Tuesday. Analysts took this opportunity to weigh in on it, and for the most part they were fairly positive......»»

Category: blogSource: 247wallstMay 1st, 2019

Emirates says full-year results will not be as good as in previous years

Dubai state-owned airline Emirates will report "positive" full-year results next month but they will not be as good as in previous years due to higher fuel costs and unfavourable currency moves, the company's president said on Monday......»»

Category: topSource: reutersApr 29th, 2019

Mustang Bio Gallops Higher On Positive Gene Therapy Results For Deadly "Bubble Boy Disease"

Shares of Mustang Bio Inc (NASDAQ: MBIO) are skyrocketing to their highest level in about a year Thursday morning. read more.....»»

Category: blogSource: benzingaApr 18th, 2019

Market Snapshot: Stocks stage late-day rally as Boeing results help Dow end lengthy losing streak

The Dow and S&P 500 ended a volatile session slightly higher on Wednesday, with the two market gauges erasing early losses to turn positive in afternoon trading as strong corporate earnings appeared to overshadow an ongoing rise in bond yields......»»

Category: topSource: marketwatchApr 25th, 2018

SBA Communications (SBAC) Q1 Earnings Top on Higher Revenues

Higher revenues backed by positive results in do.....»»

Category: dealsSource: nytMay 1st, 2018

Dollar goes positive for year, Apple results awaited

LONDON (Reuters) - The dollar broke into positive territory for the year and bond yields were creeping higher again on Tuesday, as the recent rise in oil prices fueled bets that the U.S. Federal Reserve will flag more interest rate hikes this week......»»

Category: topSource: reutersMay 1st, 2018

Williams Partners" (WPZ) Q1 Earnings Lag, Revenues Rise Y/Y

Williams Partners' (WPZ) Q1 results hurt by lower revenues from the sale of the Geismar olefins facility. Higher fee-based revenues from commissioning of Transco expansions are a positive. Williams Partners L.P.....»»

Category: personnelSource: nytMay 3rd, 2018

Benzinga"s Daily Biotech Pulse: Galmed Rips Higher On Positive NASH Data, Enzo Biochem Falls On Earnings, Pfenex Licenses Osteoporosis Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peak.....»»

Category: earningsSource: benzingaJun 12th, 2018

Benzinga"s Daily Biotech Pulse: Galmed Rips Higher On Positive NASH Data, Enzo Biochem Falls On Earnings, Pfenex Licenses Osteoporosis Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on June 11) read more.....»»

Category: blogSource: benzingaJun 12th, 2018

Sarepta Hits Record High As Duchenne Muscular Dystrophy Gene Therapy Yields Positive Results In Early-Stage Study

Sarepta Therapeutics Inc (NASDAQ: SRPT) shares, halted shortly before Tuesday's open, opened higher by more than 50 percent. read more.....»»

Category: blogSource: benzingaJun 19th, 2018

Biogen Rallies On Positive Alzheimer"s Drug Trial

Shares of Biogen Inc (NASDAQ: BIIB) soared higher by more than 13 percent early Friday morning in reaction to the results of an Alzheimer's disease study.  read more.....»»

Category: blogSource: benzingaJul 6th, 2018

Biogen stock shoots higher on Alzheimer"s drug trial

Biogen (BIIB) stock was soaring today on positive results from a recent Alzheimer's drug trial conducted along with Eisai......»»

Category: topSource: moneycentralJul 6th, 2018

Market Snapshot: Dow ends 3-day losing streak as earnings lift stocks

U.S. stocks end mostly higher on Tuesday, powered by a number of positive earnings results, including the parent company of Google that posted results that came in much stronger than expected......»»

Category: topSource: marketwatchJul 25th, 2018

With Positive Phase 2b Results In Hand, resTORbio CEO Sees Path To 2020 NDA

Shares of resTORbio, Inc. (NASDAQ: TORC) spiked as much as 119 percent higher Wednesday after the biotech announced positive topline results from a Phase 2b trial of RTB101, the company’s only candidate read more.....»»

Category: blogSource: benzingaJul 26th, 2018

Pinnacle West (PNW) Q2 Earnings Beat Estimates, Revenues Up

Pinnacle West's (PNW) Q2 results benefit from the positive impacts of higher transmission revenues. Pinnacle West Capital Corporation PNW reported adjusted earnings per share of $1.48 in the second quarter of 2018, beating th.....»»

Category: dealsSource: nytAug 3rd, 2018

Dow Jones Industrial Average (.DJI) Positive earnings results and strong economic data offset tariff concerns

Dow Jones Industrial Average (.DJI) Positive earnings results and strong economic data offset tariff concerns U.S. stocks were higher after the close on Friday, as gains in the Consumer Goods, Utilities and Telecoms sectors led shares higher. At the c.....»»

Category: topSource: livetradingnewsAug 6th, 2018

Australia: S&P/ASX 200 (.AXJO) turn flat ahead of open

Australia: S&P/ASX 200 (.AXJO) turn flat ahead of open The Australian sharemarket has closed the session higher for just the second time this month as positive reporting season results lifted the index. The S&P/ASX .....»»

Category: topSource: livetradingnewsAug 8th, 2018

Will Higher Demand Aid Toll Brothers (TOL) in Q3 Earnings?

Lack of competition in the luxury new home market and a positive housing market outlook are likely to boost Toll Brothers' (TOL) fiscal Q3 results. Toll Brothers Inc. TOL is set .....»»

Category: smallbizSource: nytAug 20th, 2018